![discount label](https://static.cymitquimica.com/public/img/discount.png)
Informação sobre produto
- (5'beta)-5'-[(2S)-butan-2-yl]-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
- (5′α)-12′-Hydroxy-2′-(1-methylethyl)-5′-[(1S)-1-methylpropyl]ergotaman-3′,6′,18-trione
- 5'alpha(S)-sec-Butyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione
- 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(1-methylpropyl)-, [5′α(S)]-
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-[(1S)-1-methylpropyl]-, (5′α)-
- Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.
- beta-Ergocryptine
- beta-Ergokryptine
- β-Ergocryptine
- Ver mais sinónimos
- β-Ergokryptine
Ergocryptine is a drug that is used to treat Parkinson’s disease. It is an active metabolite of the ergot alkaloid ergometrine. It has been shown in studies using polyclonal antibodies and casein to inhibit spontaneous activity in rats, as well as citric acid production from perennial ryegrass. Ergocryptine also inhibits biosynthesis of ergocryptine and chemical ionization of peptones from purpurea strain. It is structurally similar to ergometrine, but it does not have the same physiological effects because it lacks the methyl group on the nitrogen atom at position 2.
Propriedades químicas
Consulta técnica sobre: 3D-FE40777 b-Ergocryptine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.